International Journal of Drug Delivery Technology
Volume 15, Issue 2

Formulation Optimization and Characterization of Transdermal Patches of Luliconazole and Posaconazole by Response Surface Methodology

Vibha Saxena1,2*,  Ruchi Khare Shrivastava2 

1Department of Pharmaceutics, Dr. D. Y. Patil Institute of Pharmaceutical Sciences & Research, Pune Maharashtra, India

2Institute of Pharmaceutical Sciences, SAGE University, Indore, Madhya Pradesh, India

Received: 19th Feb, 2025; Revised: 21st Apr, 2025; Accepted: 15th May, 2025; Available Online: 25th Jun, 2025 

ABSTRACT

In the present study the transdermal drug delivery system of two anti-fungal drugs i.e., luliconazole and posaconazole was reported using surface response method. Independent variable like HPMC, E-5 and PEG and dependent variable i.e., folding endurance and in vitro release study were taken in consideration. 15 formulations having varying concentration of polymers and permeation enhancer were formulated using solvent casting method. Results indicates that R1 (folding endurance) and R2 (% drug released) ranged from 62 to 88 and 76.22 to 92.46 %. Validated values were found to be much closed to the optimized values and results were closed to the selected batches as obtained by the software’s.

Keywords: Transdermal Patches, Optimization, Characterization

How to cite this article: Vibha Saxena,  Ruchi Khare Shrivastava. Formulation Optimization and Characterization of Transdermal Patches of Luliconazole and Posaconazole by Response Surface Methodology. International Journal of Drug Delivery Technology. 2025;15(2):461-64  doi: 10.25258/ijddt.15.2.12

REFERENCES

  1. Kumar S, Deora AS, Narahari KV, Shaikh T. Optimizing Transdermal Patch Design: A Quality by Design Approach for Dysmenorrhea Relief. International Journal of Drug Delivery Technology. 2024;14(3):1299-1305.
  2. Sreedharala VN, Chintamaneni PK. Teriflunomide Transdermal Cream: In-vitro And In-vivo Evaluation for the Treatment of Rheumatoid Arthritis. International Journal of Drug Delivery Technology. 2024;14(3):1615-1622.
  3. Small G, Dubois B. A review of compliance to treatment in Alzheimer’s disease: Potential benefits of a transdermal patch. Current Medical Research and Opinion. 2007; 23(11): 2705-2713.
  4. Devi KV, Saisivam S, Maria GR, Deepti PU. Design and evaluation of matrix diffusion controlled transdermal patches of verapamil hydrochloride. Drug Development and Industrial Pharmacy, 2003; 29(3): 495-503.
  5. Tirkey F, Dwivedi A. Formulation Development and Evaluation of Transdermal Patches of Apigenin. International Journal of Drug Delivery Technology. 2024;14(3):1353-1356.
  6. Tawar P, Gehlot S, Dwivedi S, Dubey R. Development and Evaluation of Transdermal Patches of Cinnarizine for the Treatment of Allergy. International Journal of Pharmacy & Life Sciences. 2018: 9(2): 15-18.
  7. Toma NM, Abdulrasool AA. Formulation and Evaluation of Montelukast Sodium Nanoparticles for Transdermal Delivery. International Journal of Drug Delivery Technology. 2021;11(2):530-538.